Starpharma Holdings Ltd
XMUN:PQ6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Starpharma Holdings Ltd
XMUN:PQ6
|
AU |
|
O
|
Origin Energy Ltd
XMUN:ORL
|
AU |
|
P
|
ProFrac Holding Corp
NASDAQ:ACDC
|
US |
|
E
|
Ekso Bionics Holdings Inc
F:23E2
|
US |
|
Virtual Global Education Ltd
BSE:534741
|
IN |
|
R
|
Resolute Holdings Management Inc
NASDAQ:RHLD
|
US |
|
C
|
Copper Property CTL Pass Through Trust
OTC:CPPTL
|
US |
|
Enerflex Ltd
TSX:EFX
|
CA |
Wall St Price Targets
PQ6 Price Targets Summary
Starpharma Holdings Ltd
According to Wall Street analysts, the average 1-year price target for PQ6 is 0.781 EUR with a low forecast of 0.773 EUR and a high forecast of 0.804 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PQ6's stock price target?
Price Target
0.781
EUR
According to Wall Street analysts, the average 1-year price target for PQ6 is 0.781 EUR with a low forecast of 0.773 EUR and a high forecast of 0.804 EUR.
What is the Revenue forecast for Starpharma Holdings Ltd?
Projected CAGR
83%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 4 years is 83%.
What is the Gross Profit forecast for Starpharma Holdings Ltd?
Projected CAGR
-7%
The compound annual growth rate for Gross Profit over the next 11 years is -7%.
